• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肿瘤抑制因子p14ARF负向调节核糖体RNA转录并抑制上游结合因子1(UBF1)转录因子磷酸化。

Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.

作者信息

Ayrault O, Andrique L, Fauvin D, Eymin B, Gazzeri S, Séité P

机构信息

Laboratoire d'Oncologie Moléculaire. EA3805, Pô le Biologie-Santé. 40, Poitiers cedex, France.

出版信息

Oncogene. 2006 Dec 7;25(58):7577-86. doi: 10.1038/sj.onc.1209743. Epub 2006 Aug 21.

DOI:10.1038/sj.onc.1209743
PMID:16924243
Abstract

The nucleolar Arf protein has been shown to regulate cell cycle through both p53-dependent and -independent pathways. In addition to the well-characterized Arf-mdm2-p53 pathway, several partners of Arf have recently been described that could participate in alternative regulation process. Among those is the nucleolar protein B23/NPM, involved in the sequential maturation of rRNA. p19ARF can interact with B23/NPM in high molecular complexes and partially inhibit the cleavage of the 32S rRNA, whereas the human p14ARF protein has been shown to participate in the degradation of NPM/B23 by the proteasome. These data led to define Arf as a negative regulator of ribosomal RNA maturation. Our recent finding that the human p14ARF protein was able to specifically interact with the rRNA promoter in a p53-independent context, led us to analyse in vitro and in vivo the consequences of this interaction. Luciferase assay and pulse-chase experiments demonstrated that the rRNA transcription was strongly reduced upon p14ARF overexpression. Investigations on potential interactions between p14ARF and the transcription machinery proteins demonstrated that the upstream binding factor (UBF), required for the initiation of the transcriptional complex, was a new partner of the p14ARF protein. We next examined the phosphorylation status of UBF as UBF phosphorylation is required to recruit on the promoter factors involved in the transcriptional complex. Upon p14ARF overexpression, UBF was found hypophosphorylated, thus unable to efficiently recruit the transcription complex. Taken together, these data define a new p53-independent pathway that could regulate cell cycle through the negative control of rRNA transcription.

摘要

核仁Arf蛋白已被证明可通过p53依赖和非依赖途径调节细胞周期。除了已被充分研究的Arf-mdm2-p53途径外,最近还发现了Arf的几个新伙伴,它们可能参与替代调节过程。其中包括核仁蛋白B23/NPM,它参与rRNA的顺序成熟。p19ARF可在高分子复合物中与B23/NPM相互作用,并部分抑制32S rRNA的切割,而人类p14ARF蛋白已被证明参与蛋白酶体介导的NPM/B23降解。这些数据表明Arf是核糖体RNA成熟的负调节因子。我们最近发现人类p14ARF蛋白能够在不依赖p53的情况下与rRNA启动子特异性相互作用,这促使我们在体外和体内分析这种相互作用的后果。荧光素酶测定和脉冲追踪实验表明,p14ARF过表达会强烈降低rRNA转录。对p14ARF与转录机制蛋白之间潜在相互作用的研究表明,转录复合物起始所需的上游结合因子(UBF)是p14ARF蛋白的新伙伴。接下来,我们检查了UBF的磷酸化状态,因为UBF磷酸化是招募转录复合物相关启动子因子所必需的。p14ARF过表达时,UBF被发现磷酸化不足,因此无法有效招募转录复合物。综上所述,这些数据定义了一条新的不依赖p53的途径,该途径可通过对rRNA转录的负调控来调节细胞周期。

相似文献

1
Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.人类肿瘤抑制因子p14ARF负向调节核糖体RNA转录并抑制上游结合因子1(UBF1)转录因子磷酸化。
Oncogene. 2006 Dec 7;25(58):7577-86. doi: 10.1038/sj.onc.1209743. Epub 2006 Aug 21.
2
Involvement of the transcriptional factor E2F1 in the regulation of the rRNA promoter.转录因子E2F1参与核糖体RNA启动子的调控。
Exp Cell Res. 2006 Apr 15;312(7):1185-93. doi: 10.1016/j.yexcr.2006.01.027. Epub 2006 Feb 28.
3
[The negative regulation of ribosome biogenesis: a new Arf-dependent pathway controlling cell proliferation?].[核糖体生物合成的负调控:一条新的依赖Arf的控制细胞增殖的途径?]
Med Sci (Paris). 2006 May;22(5):519-24. doi: 10.1051/medsci/2006225519.
4
Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes.人类Arf肿瘤抑制因子特异性地与包含rRNA基因启动子的染色质相互作用。
Oncogene. 2004 Oct 21;23(49):8097-104. doi: 10.1038/sj.onc.1207968.
5
Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.在人类成纤维细胞中,Myc和E2F1通过不依赖p14ARF的机制诱导p53。
Oncogene. 2003 Aug 7;22(32):4993-5005. doi: 10.1038/sj.onc.1206659.
6
p14ARF interacts with E2F factors to form p14ARF-E2F/partner-DNA complexes repressing E2F-dependent transcription.p14ARF与E2F因子相互作用,形成抑制E2F依赖性转录的p14ARF-E2F/伴侣-DNA复合物。
J Cell Biochem. 2010 Mar 1;109(4):693-701. doi: 10.1002/jcb.22446.
7
Human papillomavirus 16 oncoprotein E7 stimulates UBF1-mediated rDNA gene transcription, inhibiting a p53-independent activity of p14ARF.人乳头瘤病毒 16 癌蛋白 E7 刺激 UBF1 介导的 rDNA 基因转录,抑制 p14ARF 的 p53 非依赖性活性。
PLoS One. 2014 May 5;9(5):e96136. doi: 10.1371/journal.pone.0096136. eCollection 2014.
8
8-Chloro-adenosine-induced E2F1 promotes p14ARF gene activation in H1299 cells through displacing Sp1 from multiple overlapping E2F1/Sp1 sites.8-氯腺苷诱导的E2F1通过将Sp1从多个重叠的E2F1/Sp1位点置换出来,促进H1299细胞中p14ARF基因的激活。
J Cell Biochem. 2009 Feb 15;106(3):464-72. doi: 10.1002/jcb.22033.
9
Nucleolar localization of aprataxin is dependent on interaction with nucleolin and on active ribosomal DNA transcription.共济失调性毛细血管扩张症突变蛋白的核仁定位取决于与核仁素的相互作用以及活跃的核糖体DNA转录。
Hum Mol Genet. 2006 Jul 15;15(14):2239-49. doi: 10.1093/hmg/ddl149. Epub 2006 Jun 15.
10
In vitro and in vivo analysis of the interaction between 5.8S rRNA and ARF protein reveal a new difference between murine p19ARF and human p14ARF.对5.8S核糖体RNA与ARF蛋白之间相互作用的体外和体内分析揭示了小鼠p19ARF和人类p14ARF之间的一个新差异。
Oncogene. 2005 Apr 7;24(15):2580-4. doi: 10.1038/sj.onc.1208457.

引用本文的文献

1
The Nucleolus: A Central Hub for Ribosome Biogenesis and Cellular Regulatory Signals.核仁:核糖体生物发生和细胞调节信号的中心枢纽
Int J Mol Sci. 2025 Apr 28;26(9):4174. doi: 10.3390/ijms26094174.
2
Functions of the native NPM1 protein and its leukemic mutant.天然NPM1蛋白及其白血病突变体的功能。
Leukemia. 2025 Feb;39(2):276-290. doi: 10.1038/s41375-024-02476-4. Epub 2024 Dec 17.
3
Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer.靶向核糖体生物发生增强了胰腺癌细胞中 ERK 依赖性衰老。
Cell Cycle. 2023 Oct;22(19):2172-2193. doi: 10.1080/15384101.2023.2278945. Epub 2023 Dec 5.
4
Regulation of RNA Polymerase I Stability and Function.RNA聚合酶I稳定性与功能的调控
Cancers (Basel). 2022 Nov 24;14(23):5776. doi: 10.3390/cancers14235776.
5
Ribosomal RNA Transcription Regulation in Breast Cancer.核糖体 RNA 转录调控在乳腺癌中的作用。
Genes (Basel). 2021 Mar 29;12(4):502. doi: 10.3390/genes12040502.
6
Upregulation of 5'-terminal oligopyrimidine mRNA translation upon loss of the ARF tumor suppressor.ARF 肿瘤抑制因子失活后 5'-末端寡嘧啶 mRNA 翻译的上调。
Sci Rep. 2020 Dec 17;10(1):22276. doi: 10.1038/s41598-020-79379-8.
7
How Cancer Exploits Ribosomal RNA Biogenesis: A Journey beyond the Boundaries of rRNA Transcription.癌症如何利用核糖体 RNA 生物发生:超越 rRNA 转录边界的探索之旅。
Cells. 2019 Sep 17;8(9):1098. doi: 10.3390/cells8091098.
8
Therapeutic Approaches Targeting Nucleolus in Cancer.治疗癌症的核仁靶向方法。
Cells. 2019 Sep 16;8(9):1090. doi: 10.3390/cells8091090.
9
Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging.核糖体生物合成受损:机制及其与癌症和衰老的关联
Aging (Albany NY). 2019 Apr 26;11(8):2512-2540. doi: 10.18632/aging.101922.
10
Nuclear ERK: Mechanism of Translocation, Substrates, and Role in Cancer.核 ERK:易位机制、底物及在癌症中的作用。
Int J Mol Sci. 2019 Mar 8;20(5):1194. doi: 10.3390/ijms20051194.